DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31

QUEST DIAGNOSTICS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 23, 2026

$234.91−0.09 (-0.04%)

Close on Oct 19, 2026

Market cap: $26.31B
P/E (TTM): 25.0
Dividend yield: –

QUEST DIAGNOSTICS INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31
Revenue	11,035	9,872	9,252	9,883	10,788	9,437	7,726	7,531	7,402	7,214	7,493	7,435	7,146	7,383	7,392	7,260	7,455	7,249	6,705
Cost of Revenue	7,370	6,628	6,199	6,450	6,579	5,804	5,037	4,926	4,719	4,616	4,657	4,637	4,326	4,365	4,363	4,276	4,321	4,256	3,970
Gross Profit	3,665	3,244	3,053	3,433	4,209	3,633	2,689	2,605	2,683	2,899	2,836	2,798	2,820	3,018	3,029	3,052	3,134	2,993	2,735
Selling, General & Admin	1,967	1,770	1,642	1,874	1,727	1,550	1,457	1,424	1,443	1,380	1,679	1,728	1,704	1,745	1,743	1,659	1,748	1,737	1,613
Advertising Expenses	35	28	31	74	78	38	18	–	–	–	–	–	–	–	–	–	–	–	–
Total Costs & Expenses	9,479	8,526	7,990	8,455	8,407	7,466	6,495	6,430	6,237	5,937	6,094	6,452	5,671	6,182	6,405	5,977	6,096	6,027	5,614
Operating Income	1,556	1,346	1,262	1,428	2,381	1,971	1,231	1,101	1,165	1,277	1,399	983	1,475	1,201	987	1,284	1,359	1,222	1,091
Interest Expense	–	–	163	148	152	166	180	169	153	144	154	167	–	–	173	148	147	-185	–
Interest & Investment Income	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.77	1.41	2.52	5.71	–
Income from Equity Investments	42	19	26	44	78	75	57	44	35	39	23	26	24	26	29	30	33	30	27
Other Non-Operating Income	-238	-171	-132	-193	218	-87	-155	-175	-135	-191	-296	-160	-151	-133	-138	-109	-131	-172	-152
Merger & Restructuring Charges	–	–	–	55	13	14	-3.00	49	30	11	39	43	75	–	–	–	–	–	–
Asset Impairment Charges	0	0	0	0	–	–	–	–	–	–	16	–	–	–	–	–	–	–	–
Gain (Loss) on Investments	19	18	20	-55	56	8.00	10	-2.00	8.00	–	–	–	–	–	3.00	3.30	6.00	-9.90	–
Gain (Loss) on Sale of Assets	–	–	–	–	-9.00	-3.00	70	-6.00	-2.00	118	334	0	0	–	–	–	–	–	–
Pretax Income	1,318	1,175	1,130	1,235	2,599	1,884	1,076	926	1,030	1,086	1,103	823	1,324	–	856	1,184	1,228	1,051	–
Income Tax Expense	314	273	248	264	597	460	247	182	241	429	373	262	500	402	355	430	460	387	359
Income from Continuing Operations	–	–	–	–	1,995	1,431	838	736	772	645	709	551	814	630	459	709	730	632	554
Income from Discontinued Operations	–	–	–	–	0	0	20	0	0	0	0	5.00	35	-74	12	12	-1.24	-51	-214
Net Income incl. Noncontrolling Interests	1,046	921	908	1,015	2,080	1,499	906	788	824	696	753	592	883	592	506	757	766	613	366
Minority Interest in Earnings	54	50	54	69	85	68	48	52	52	51	44	36	34	36	35	36	37	32	27
Net Income	992	871	854	946	1,995	1,431	858	736	772	645	709	556	849	556	471	721	729	581	340
Net Income to Common	–	–	–	–	–	–	–	733	769	642	706	549	–	–	–	–	–	–	–
EPS (Basic)(per share)	8.87	7.78	7.59	8.10	15.85	10.62	6.36	5.39	5.63	4.58	4.92	3.83	5.58	3.49	2.95	4.08	3.91	2.99	1.76
EPS (Diluted)(per share)	8.75	7.69	7.49	7.97	15.55	10.47	6.28	5.29	5.50	4.51	4.87	3.81	5.54	3.46	2.92	4.05	3.87	2.96	1.74
Shares Outstanding (Basic, Weighted)(shares)	111	111	112	116	125	134	134	136	137	140	144	145	152	159	159	176	186	194	–
Shares Outstanding (Diluted, Weighted)(shares)	113	113	113	118	128	136	136	139	140	142	145	145	153	160	160	177	188	196	–
Dividend per Share(per share)	–	–	–	–	–	–	–	–	1.80	1.65	1.52	1.32	1.20	0.81	0.47	0.40	0.40	0.40	0.40
EBITDA	2,126	1,839	1,701	1,865	2,789	2,332	1,560	1,410	1,435	1,526	1,703	1,297	1,758	1,488	1,268	1,538	1,616	1,487	1,329
Total Interest Income	13	25	11	10	1.00	3.00	5.00	2.00	2.00	1.00	1.00	3.00	–	–	–	–	–	–	–
Net Interest Income	-264	-201	-152	-138	-151	-163	-175	-167	-151	-143	-153	-164	-159	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 33.1%
Operating margin: 14.1%
Net margin: 9.2%
Return on equity, FY2025: 14.2%

Financial strength

Current ratio: 1.59
Debt to equity: 0.75
Debt to assets: 33.3%
Cash to current liabilities: 35.0%

Valuation

P/E ratio: 25.0
Price to sales: 2.28
Price to book: 3.50
Dividend yield: –